Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
These initiatives were driven by Baroness Finlay of Llandaff, and are more likely to reflect personal policy preferences.
The provisions of the Bill were ultimately enacted through the Online Safety Act 2023.
A Bill to require OFCOM to establish a unit to advise the Secretary of State regarding the use of social media platforms to encourage or assist serious self-harm and activities associated with risk of suicide; and for connected purposes
A Bill to make provision for equitable access to palliative care services; for advancing education, training and research in palliative care; and for connected purposes
A bill to make provision for NHS service commissioners to ensure that persons for whom they have responsibility for commissioning physical and mental health services have access to specialist and generalist palliative care and support services; to enable hospices to access pharmaceutical services on the same basis as other services commissioned by a clinical commissioning group; and to make provision for treatment of children with a life-limiting illness
A Bill to make provision for equitable access to palliative care services; for advancing education, training and research in palliative care; and for connected purposes.
Baroness Finlay of Llandaff has not co-sponsored any Bills in the current parliamentary sitting
DfT is committed to long term strategies for road investment. As announced in the October Budget, a decision was taken to postpone the start of the third Road Investment Strategy (RIS3), to allow Ministers time to make an assessment of priorities for roads. DfT will provide funding through an Interim Settlement to National Highways covering 2025-26, to allow for important maintenance and enhancement activities to continue. The planned start of RIS3 is April 2026 and the drink-drive limit will not form part of the RIS.
This Government takes road safety seriously, and we are committed to reducing the numbers of those killed and injured on our roads. Since the general election, the Department has begun work on a new Road Safety Strategy, the first in over a decade. The Department will share more details in due course.
Both NHS England and integrated care boards (ICBs) are required to put in place access for any treatment that carries a positive recommendation from the Technology Appraisal programme, operated by the National Institute for Health and Care Excellence (NICE).
Where treatments are approved by NICE through the Technology Appraisals programme, the National Health Service is required to fund and make them available within agreed timescales, which vary by technology. Implementation of any NICE approvals will be supported by the service readiness assessment and the development of additional capacity where necessary.
During 2024/25, NHS England will continue to support all ICBs in integrating the planning and commissioning of suitable specialised services with their wider population-level commissioning responsibilities, in line with their individual timeline for delegation. Service Development Funding (SDF) is available to support Cancer Alliances to deliver the priorities set out in the 2024/25 NHS Operational Planning Guidance; £266 million in SDF is being provided to Cancer Alliances in 2024/25. Funding comprises two allocations: place-based, provided to all Alliances on a fair shares basis; and, targeted, provided to a selection of Alliances for agreed targeted projects. Cancer SDF is provided to Cancer Alliances via their lead ICBs to enable them to deliver on NHS-wide priorities for cancer, in line with their local delivery plans which are included in their funding agreement.
The adoption of new treatments, including increasing the number and availability of minimally invasive cancer treatments, into the National Health Service in England is generally the result of National Institute for Health and Care Excellence (NICE) guidance and commissioner decisions. Both NHS England and the integrated care boards (ICBs) are required to put in place access for any treatment that carries a positive recommendation from the Technology Appraisal programme, operated by the NICE.
Where treatments are approved by the NICE through the Technology Appraisals programme, the NHS is required to fund and make them available within agreed timescales, which vary by technology. Implementation of any NICE approvals will be supported by the service readiness assessment and the development of additional capacity where necessary.
During 2024/25, NHS England will continue to support all ICBs in integrating the planning and commissioning of suitable specialised services with their wider population-level commissioning responsibilities, in line with their individual timeline for delegation.
We are committed to training the staff we need to get patients seen on time. The Government will make sure the NHS has the staff it needs to be there for all of us when we need it, including cancer patients.
Good practice for homecare is set out in the National Institute for Health and Care Excellence’s (NICE) guidance, which can be found on the NICE’s website, in an online only format.
Services need to submit statutory notifications to the Care Quality Commission (CQC) when a medicines incident reaches a specific threshold. This includes an allegation of abuse, the death of a person, an incident reported to or investigated by the police, or a serious injury.
Data on anything that does not constitute the CQC threshold is not held by the CQC, but may be held by individual providers as a recorded incident.